 Bellicum Pharmaceuticals Inc NASDAQ:BLCM was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 417,700 shares, a decline of 29.1 from the March 15th total of 589,100 shares. Based on an average trading volume of 161,100 shares, the days-to-cover ratio is ... 